House Passes Healthcare Bill with 340B Provider Reporting Requirements

A sweeping healthcare package with 340B reporting provisions from Rep. Cathy McMorris Rodgers (R-Wash.) was passed by the House of Representatives.
The U.S. House of Representatives last night passed a sweeping healthcare package that would require 340B providers to publicly report [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Legislation ‘Is Coming’ to Address Contract Pharmacy Restrictions, Hospital Advocate Says

Maureen Testoni headshot
Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.
Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Missouri State Senator to Reintroduce 340B Contract Pharmacy, PBM Protection Bill

The Missouri state senate recently passed a 340B contract pharmacy access bill.
A Missouri state senator has filed to reintroduce a bill that would bar drugmaker 340B contract pharmacy restrictions and pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Wisconsin Assembly Bill Introduced to Bar PBM Practices Against 340B Providers

Wisconsin lawmakers have introduced bills in both legislative chambers that would bar PBMs from differentially reimbursing providers on the basis of their 340B status.
Just a week after Wisconsin state senators introduced a bipartisan bill to bar disparate treatment of 340B providers by pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers Highlight 340B Developments in Earnings Calls

Jean-Jacques Bienaime, CEO of drugmaker BioMarin, discussed the impact of 340B on pharmaceutical sales during an investor earnings call.
Pharmaceutical company executives discussed a range of 340B-related developments in recent third quarter investor calls. An executive for BioMarin Pharmaceutical, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House Committee Approves PBM Transparency Bill with 340B Provision

The House E&C Committee on Dec. 6 unanimously approved a PBM transparency bill with a 340B program provision.
Lawmakers on a key House committee approved a pharmacy benefit manager (PBM) transparency bill on Wednesday that would require PBMs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Part B Drug Claims Modifier Requirement for 340B Entities Starts Jan. 1

CMS
In response to the ongoing Change Healthcare cyberattack, CMS will direct contractors to provide some accelerated payments to hospitals.
Critical access hospitals (CAHs) and Ryan White HIV/AIDS clinics do not expect problems implementing a new requirement starting Jan. 1, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Four 340B Terminations, Eight Paybacks to Manufacturers in Latest Provider Audit Findings

HRSA provider audits
Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of two more 340B providers.
Federal auditors determined terminations from the 340B program were required for either covered entity sites or contract pharmacies of four [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Biogen Adds Drug with Narrow Approval to 340B Contract Pharmacy Restrictions

Biogen wordmark on building facade
Drugmaker Biogen recently added a third drug to its 340B contract pharmacy restrictions for hospitals.
Biopharmaceutical manufacturer Biogen recently expanded its contract pharmacy restrictions for hospitals to a third drug, after that medication garnered a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Reforms Needed, Says Former Presidential Candidate, Drug Industry Consultant

Howard Dean, a former Democratic presidential candidate who has consulted for the drug industry, said the 340B program is in need of reforms.
The 340B program has become “a multibillion-dollar boondoggle for hospital mega-chains” and needs reform, says Howard Dean, a one-time Democratic [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live